• 1
    Yoon, P. W., S. B. Freeman, S. L. Sherman, L. F. Taft, Y. Gu, D. Pettay, et al. 1996. Advanced maternal age and the risk of Down syndrome characterized by the meiotic stage of chromosomal error: a population-based study. Am. J. Hum. Genet. 58:628633.
  • 2
    Arron, J. R., M. M. Winslow, A. Polleri, C. P. Chang, H. Wu, X. Gao, et al. 2006. NFAT dysregulation by increased dosage of DSCR1 and DYRK1A on chromosome 21. Nature 441:595600.
  • 3
    Meyers, C. M., S. Ghori, A. E. Roberson, M. G. Blitzer, and M. M. Cohen. 1997. 46, XY, i(21q) identified by maternal serum screening. Md. Med. J. 46:8889.
  • 4
    Graf, M. D., P. Gill, M. Krew, S. Schwartz. 2002. Prenatal detection of structural abnormalities of chromosome 18: associations with interphase fluorescence in situ hybridization (FISH) and maternal serum screening. Prenat. Diagn. 22:645648.
  • 5
    Test and Technology Transfer Committee. 2000. Technical and clinical assessment of fluorescence in situ hybridization: an ACMG/ASHG position statement. I. Technical considerations. Genet. Med. 2:356361.
  • 6
    Pinkel, D., R. Segraves, D. Sudar, S. Clark, I. Poole, D. Kowbel, et al. 1998. High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays. Nat. Genet. 20:207211.
  • 7
    Rauch, A., F. Ruschendorf, J. Huang, U. Trautmann, C. Becker, C. Thiel, et al. 2004. Molecular karyotyping using an SNP array for genomewide genotyping. J. Med. Genet. 41:916922.
  • 8
    Korenberg, J. R., X. N. Chen, R. Schipper, Z. Sun, R. Gonsky, S. Gerwehr, et al. 1994. Down syndrome phenotypes: the consequences of chromosomal imbalance. Proc. Natl. Acad. Sci. USA 91:49975001.
  • 9
    Ronan, A., K. Fagan, L. Christie, J. Conroy, N. J. Nowak, G. Turner. 2007. Familial 4.3 Mb duplication of 21q22 sheds new light on the Down syndrome critical region. J. Med. Genet. 44:448451.
  • 10
    Schinzel, A. 2001. Catalogue of unbalanced chromosome aberrations in man, 2nd ed. de Gruyter, Berlin, New York, NY.